Merith Basey MSc
@MerithBasey
No one should be sick because they are poor or be poor because they are sick. CEO for @P4AD_ @P4ADNOW. Opinions mine. Se habla español. #drugpricing
You might like
We’re jumping on the 2016 trend! In 2016 (and well before), @MerithBasey was part of the fight for lower drug costs. Two decades ago, she was working with children and young people living with type 1 diabetes in Latin America, where she saw what happens when life-saving medicine…
Product hopping is just one of the many harmful tactics pharma uses to keep prices high. By abusing the patent system, big drug companies can avoid generic and biosimilar market competition and keep prices high. Learn how we can fight back at PatientsPushForCompetition.Org
Bravo! We'll be pre-ordering at @P4AD_ ! #PharmaGreedKills
NEWS: @realtahiramin and Rohit Malpani are releasing a new book! 📚 In it, they examine the origins of a global public health system that protects pharmaceutical monopolies instead of the public interest and people’s lives.
ACoM News Briefing Recap | How Soaring Costs Are Reshaping Health Care Access | See More: buff.ly/iDCDapi | A new media briefing explores how rising health care costs are transforming access to care across the United States. With health care spending now accounting for…
Thanks to Medicare Negotiation, P4AD Patient Advocate, Jackie Trapp, feels like she can finally focus her energy on fighting her cancer instead of worrying about how she’s going to pay for her medications every month. Her drug, Xarelto, is one of the ten drugs that saw a lower…
We will be closely watching how Eli Lilly and Novo Nordisk adapt their patenting schemes to maintain monopoly control and delay affordable options for the GLP-1 market. To date, Novo Nordisk has filed 320 patent applications on its semaglutide products while Eli Lilly has filed…
We will continue to fight for the world that David dreamed of, a world where lifesaving medicines can be within reach of every patient. Rest in power, David.
A statement from Chuck Hurley, Board Chair of Patients For Affordable Drugs and David’s close friend of more than 40 years, honoring David’s life and legacy following his passing on Friday. patientsforaffordabledrugs.org/2026/01/05/rem…
On Friday, the world lost a fierce patient advocate & a tireless leader who dedicated his life 2 others. Personally, I lost a mentor & a dear friend. I know our team will channel our grief into further action in his honor. It's an understatement 2 say he will be greatly missed.
A statement from Chuck Hurley, Board Chair of Patients For Affordable Drugs and David’s close friend of more than 40 years, honoring David’s life and legacy following his passing on Friday. patientsforaffordabledrugs.org/2026/01/05/rem…
A statement from Chuck Hurley, Board Chair of Patients For Affordable Drugs and David’s close friend of more than 40 years, honoring David’s life and legacy following his passing on Friday. patientsforaffordabledrugs.org/2026/01/05/rem…
RIP, David Mitchell, founder of Patients for Affordable Drugs and an incredible human being. David entered health policy as a patient. Diagnosed with a form of leukemia and dependent on an expensive medication, he experienced firsthand how opaque pricing could place crushing…
P4AD's Merith Basey @GlobalDiaBEATes and Michael Lieberman @Footnote24 joined McGill to discuss pharma's legal crusade to end drug price negotiations, and how we're fighting back — listen below! open.spotify.com/episode/6Lptc1…
“Expediting the biosimilar approval process – by cutting unnecessary red tape and streamlining duplicative clinical trials – will help speed lower-cost treatments … delivering relief to patients” more from @P4ADNOW on recent @FDA action: patientsforaffordabledrugsnow.org/2025/10/29/sta…
👏👏👏
Rather than strengthening Medicare negotiation, bills have passed to further exempt or delay negotiation for even more drugs approved for rare diseases. For example, price negotiations for Jakafi, approved for rare bone marrow cancer and other non-rare blood conditions, are…
🆕 BIG NEWS! 🆕 Are you looking for an easy way to be part of P4AD’s fight for affordable medicine? Now you can help fuel the travel, training, and organizing that gets patients face-to-face with the people in power all with the click of a button! Every purchase from our new…
Patients with MS like Sarah should be able to afford the medications they need to live full and productive lives. Have you or someone in your family struggled to afford prescription drug costs? Your voice matters, share your story today: actionnetwork.org/forms/base-sto…
THREE more wins for US Patients V Big Pharma.
Here's a roundup of some good coverage of the Medicare drug price negotiation lawsuits. In just 48 hours, federal courts delivered three major defeats to Big Pharma's lawsuits against Medicare negotiation. These rulings are a huge win for patients, reinforcing that this…
New from @JosefChoi: "This decision marks the 10th court ruling in favor of patients" @GlobalDiaBEATes: "By upholding the lower court’s decision, the U.S. Court of Appeals is siding with American patients who deserve a much better deal" thehill.com/policy/healthc…
"'This policy will basically provide a loophole for pharma to enable them to keep more expensive drugs on the market at high prices,' said Merith Basey, executive director of Patients for Affordable Drugs." @GlobalDiaBEATes
Reforming the patent system is key to lower prescription drug costs - and its bipartisan! freopp.org/oppblog/prescr…
Don't be deceived: OPRHAN Cures is a harmful $5 billion giveaway to pharma & will increase drug prices for patients. Tell your Senator to vote against its inclusion in the reconciliation bill. actionnetwork.org/letters/contac…
United States Trends
- 1. Porzingis N/A
- 2. Kuminga N/A
- 3. Warriors N/A
- 4. Gonzaga N/A
- 5. Skubal N/A
- 6. Podz N/A
- 7. Hield N/A
- 8. Dalen Terry N/A
- 9. #AEWDynamite N/A
- 10. Yabu N/A
- 11. Ty Jerome N/A
- 12. POTS N/A
- 13. #DubNation N/A
- 14. Knicks N/A
- 15. Lobos N/A
- 16. Trey Murphy N/A
- 17. Zags N/A
- 18. Draymond N/A
- 19. Golden State N/A
- 20. Flagstaff N/A
You might like
Something went wrong.
Something went wrong.